【编号】:SPR04248
【产品名称】:Eupahualin C对照品
【规格】:10mg
【用途】:
【简单介绍】
【详细说明】
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
MPI_5a 纯度: ≥99.0%
MPI_5a 是一种高效、选择性的 HDAC6 抑制剂 (IC50=36 nM)。MPI_5a 对其他 HDAC 酶的抑制作用很弱。MPI_5a 抑制细胞内酰基微管蛋白的积累的 IC50 值为 210 nM。
MPI_5a Chemical Structure
CAS No. : 1259296-46-2
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
1 mg (16.7 mM * 200 μL in Acetonitrile) | ¥4100 | In-stock | |
5 mg (16.7 mM * 1 mL in Acetonitrile) | ¥12500 | In-stock |
* Please select Quantity before adding items.
生物活性 |
MPI_5a is a potent and selective HDAC6 inhibitor (IC50=36 nM). MPI_5a weakly inhibits other HDAC isoforms. MPI_5a inhibits acyl-tubulin accumulation in cells with an IC50 value of 210 nM[1]. |
---|---|
分子量 |
299.32 |
Formula |
C16H17N3O3 |
CAS 号 |
1259296-46-2 |
运输条件 |
Room temperature in continental US; may vary elsewhere. |
储存方式 |
Solution, -20°C, 2 years |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
trans-AUCB (Synonyms: t-AUCB) 纯度: 98.11%
trans-AUCB (t-AUCB) 是一种有效的,具有口服活性和选择性的可溶性环氧水解酶 (sEH) 抑制剂,对 人,小鼠和大鼠的 sEH 的 IC50 分别为 1.3 nM,8 nM,8 nM。trans-AUCB 具有抗神经胶质瘤活性。
trans-AUCB Chemical Structure
CAS No. : 885012-33-9
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥1316 | In-stock | |
1 mg | ¥500 | In-stock | |
5 mg | ¥1450 | In-stock | |
10 mg | ¥2550 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
trans-AUCB (t-AUCB) is a potent, orally active and selective soluble epoxide hydrolase (sEH) inhibitor with IC50s of 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively. trans-AUCB has anti-glioma activity[1][2]. |
IC50 & Target |
IC50: 1.3 nM (hsEH), 8 nM (mouse sEH) and 8 nM (rat sEH)[2] |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
trans-AUCB (t-AUCB; 25-300 μM; 48 hours) suppresses U251 and U87 cell growth in a dose-dependent manner[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay[1]
Cell Cycle Analysis[1]
Western Blot Analysis[1]
|
||||||||||||||||||||||||
体内研究 (In Vivo) |
trans-AUCB (t-AUCB; p.o.; 0.1, 0.5, 1 mg/kg) ameliorates the LPS-induced hypotension in a dose-dependent manner[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||||||||||||||
分子量 |
412.52 |
||||||||||||||||||||||||
Formula |
C24H32N2O4 |
||||||||||||||||||||||||
CAS 号 |
885012-33-9 |
||||||||||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||||||
储存方式 |
|
||||||||||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (242.41 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Cyclopamine (Synonyms: 环巴胺; 11-Deoxojervine) 纯度: 99.97%
Cyclopamine 是 Hedgehog 通路的拮抗剂,在细胞实验中的 IC50 为 46 nM。Cyclopamine 还是一种选择性的 Smo 抑制剂。
Cyclopamine Chemical Structure
CAS No. : 4449-51-8
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥870 | In-stock | |
10 mg | ¥1300 | In-stock | |
50 mg | ¥3348 | In-stock | |
100 mg | ¥5440 | In-stock | |
200 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
Cyclopamine is a Hedgehog (Hh) pathway antagonist with an IC50 of 46 nM in the Hh cell assay. Cyclopamine is also a selective Smo inhibitor. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
体外研究 (In Vitro) |
Treatment with small molecule Hh inhibitors such as HhAntag and the natural product Cyclopamine, both binding to Smo, induces tumor remission in a genetic mouse model of medulloblastoma[1]. Cyclopamine is a Hedgehog (Hh) pathway antagonist. Cyclopamine suppresses cell growth. Cyclopamine (3 μM) suppression of Hh pathway activity and growth in digestive tract tumour cell lines correlates with expression of PTCHmRNA[2]. Cyclopamine is a steroidal alkaloid that inhibits Hh signalling through direct interaction with Smo[3]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
Cyclopamine causes durable regression of xenograft tumors. Tumors in Cyclopamine-treated animals, regress completely by 12 days[2]. Cyclopamine (1.2 mg) treatment blocks tumour formation of human pancreatic adenocarcinoma cells after transplantation into nude mice[3]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
411.62 |
||||||||||||||||
Formula |
C27H41NO2 |
||||||||||||||||
CAS 号 |
4449-51-8 |
||||||||||||||||
中文名称 |
环杷明;环巴胺;11-去氧芥芬胺 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
Ethanol : 33.33 mg/mL (80.97 mM; Need ultrasonic) DMSO : 10 mg/mL (24.29 mM; ultrasonic and warming and heat to 80°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
Cell Assay [2] |
Cells are cultured in triplicate in 96-well plates in assay media to which 5E1 monoclonal antibody, ShhNp and/or Cyclopamine (3 μM) are added at 0 h at concentrations indicated in the main text. Viable cell mass is determined by optical density measurements at 490 nm (OD490) at 2 and 4 days using the CellTiter96 colorimetric assay. Relative growth is calculated as OD (day 4)-OD (day 2)/OD (day 2)[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
---|---|
Animal Administration [3] |
Mice[3] 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
【简单介绍】
【详细说明】
宁波新芝聚能恒温超声波萃取仪Scientz-500C
产品说明
1、C系列聚能恒温超声萃取仪是应用现代超声波技术结合智能低温恒温系统作为物理手段的新型超声波萃取/提取装置
主要由大功率超声波发生系统、加热系统、压缩机制冷系统、测温控温系统、搅拌系统等组成。
2、采用20KHz聚焦式大功率超声波换能器,直接将超声波探头浸入盛放物料的容器中,温度传感器对物料进行测温
把盛有物料的容器放入恒温容器内,可以根据用户的需要设置所需温度,使物料在低温恒温的环境下在超声波的直接作用下充分快速的萃取/提取。
产品特征
1、采用触摸屏集成控制技术
2、超声波采用锁相环频率自动跟踪技术
3、友好美观的人机界面操作即可设置数据、存储数据和控制工作状态
4、换能器的振荡频率经相位取样使锁相环实现频率自动跟踪
5、功率设定和温度测量电路使单片机实现超声波发射功率和超温保护及报警功能
6、7寸TFY触摸屏显示
技术参数
型号 |
Scientz-500C |
超声功率MAX |
900 W |
反应瓶容积 |
500 ml |
探头直径 |
Ф10 mm |
功率可调范围 |
15%-100% |
超声频率 |
22KHz±1KHz |
超声总时间 |
1-999 min可设 |
超声时间 |
1-99 S可设 |
间隙时间 |
1-99 S可设 |
搅 拌 仪 |
1%-30%可设(最高转速1000 r/min)有需要的用户可选购与四口瓶配用 |
压缩机功率 |
500 W |
加热功率 |
2000 W |
控温方式 |
PID自动控温 |
测温方式 |
双通道测温,监控反应体系和恒温工作槽内实时温度。 |
控温范围 |
0-99 ℃ |
控温波动度 |
≦±1 ℃ |
恒温容积 |
6 L |
异常报警功能 |
有,设备具有故障自诊断及报警提示功能 |
运行记录方式 |
设备具有工作曲线画面,全程记录运行中温度等参数变化信息 |
设备控制方式 |
7寸TFT触摸屏显示与单片机集成控制 |
设备操作方式 |
触屏上直接操作,设置温度、功率、时间等参数 |
USB通讯口 |
设备自带USB通讯口,插上优盘,可将曲线等信息以图片形式保存到优盘 |
远程通讯串口 |
此功能为选配项,有需要的用户可选购(含上位机软件)与电脑相连 |
反 应 瓶 |
常规为三口瓶,有需要的用户可选购五口瓶 |
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Bosutinib D8 (Synonyms: SKI-606 D8)
Bosutinib D8 (SKI-606 D8) 是 Bosutinib 的氘代物。Bosutinib 是 Src/Abl 的双抑制剂, IC50 分别为 1.2 nM 和 1 nM。
Bosutinib D8 Chemical Structure
规格 | 价格 | 是否有货 | |
---|---|---|---|
1 mg | ¥2250 | 询问价格 & 货期 |
* Please select Quantity before adding items.
生物活性 |
Bosutinib D8 (SKI-606 D8) is a deuterium labeled Bosutinib. Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively[1][2]. |
IC50 & Target |
IC50: 1.2 nM (Src), 1 nM (Abl)[1] |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
538.50 |
||||||||||||
Formula |
C26H21D8Cl2N5O3 |
||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
储存方式 |
|
||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Sparfosic acid trisodium 纯度: 99.65%
Sparfosic acid trisodium 是天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂,具有抗肿瘤和抗代谢物活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。Sparfosic acid trisodium 协同增强 5-氟尿嘧啶 (5-FU) 和干扰素-α (IFN) 对人结肠癌细胞系的细胞毒性。
Sparfosic acid trisodium Chemical Structure
CAS No. : 70962-66-2
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥4180 | In-stock | |
5 mg | ¥3800 | In-stock | |
10 mg | ¥6000 | In-stock | |
50 mg | ¥19800 | In-stock | |
100 mg | ¥29500 | In-stock | |
200 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
Sparfosic acid trisodium is a DNA antimetabolite agent and a potent inhibitor of aspartate transcarbamoyl transferase. Aspartate transcarbamoyl transferase catalyzes the second step of de novo pyrimidine biosynthesis. Sparfosic acid trisodium synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines[1][2][3]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Sparfosic acid (N-(Phosphonacetyl)-L-aspartate, PALA) treatment causes apoptosis in the resistant Br1 cells[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cycle Analysis[1]
Western Blot Analysis[1]
|
||||||||||||||||
体内研究 (In Vivo) |
Sparfosic acid (490 mg/kg; i.p.; on days 1, 5, and 9; mice bearing B16 melanoma) trisodium shows the life-span is increased survives 77 to 86% longer than controls. Lewis lung carcinoma is highly sensitive to Sparfosic acid trisodium. Treatment on days 1, 5, and 9 following s.c. implantation of Lewis lung carcinoma is curative to 50% of the mice[4]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
321.06 |
||||||||||||||||
Formula |
C6H7NNa3O8P |
||||||||||||||||
CAS 号 |
70962-66-2 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
-80°C, protect from light, stored under nitrogen |
||||||||||||||||
溶解性数据 |
In Vitro:
H2O : 250 mg/mL (778.67 mM; Need ultrasonic) DMSO : 180 mg/mL (560.64 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
【编号】:SPR04210
【产品名称】:Eicosanyl caffeate对照品
【规格】:10mg
【用途】:
【简单介绍】
【详细说明】
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Nivolumab (Synonyms: 纳武单抗; BMS-936558; ONO-4538; MDX-1106) 纯度: 98.56%
Nivolumab 是一种 PD-1 人源类 IgG4 抗体类抑制剂,用于晚期(转移性)非小细胞肺癌的研究。
Nivolumab Chemical Structure
CAS No. : 946414-94-4
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
1 mg | ¥2700 | In-stock | |
5 mg | ¥5700 | In-stock | |
25 mg | 询价 | ||
50 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer. |
---|---|
体外研究 (In Vitro) |
Nivolumab binds to CHO cells expressing PD-1 with an EC50 of 1.66 nM, but does not bind to the parental CHO cell line. Nivolumab binds to PD-1 on activated T cells with an EC50 of 0.64 nM. Nivolumab also inhibits the interaction between PD-1 and its ligands, PD-L1 and PD-L2, with IC50 values of 2.52 and 2.59 nM, respectively. Nivolumab (1.5 ng/mL) can enhance T-cell reactivity in the presence of a T-cell receptor stimulus[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
体内研究 (In Vivo) |
Nivolumab (10 and 50 mg/kg, i.v.) is well tolerated in cynomolgus monkeys. Serum chemistry changes are limited to a reversible 28% decrease in T3 at week 13 in females treated with 50 mg/kg. T4 and TSH levels are unchanged. In males treated with 50 mg/kg, there are no changes in T3, T4, or TSH levels. Nivolumab exposure increases in an approximately dose-proportional manner between 10 and 50 mg/kg, with no substantial sex differences noted[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
Clinical Trial |
|
分子量 |
143599.09 |
CAS 号 |
946414-94-4 |
中文名称 |
纳武单抗;尼鲁单抗 |
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Erlotinib-d6 hydrochloride (Synonyms: CP-358774-d6 hydrochloride; NSC 718781-d6 hydrochloride; OSI-774-d6 hydrochloride) 纯度: 98.13%
Erlotinib D6 hydrochloride (CP-358774 D6 hydrochloride) 是 Erlotinib Hydrochloride 的一种氘代化合物。Erlotinib Hydrochloride 抑制 EGFR 激酶的 IC50 为 2 nM 。
Erlotinib-d6 hydrochloride Chemical Structure
CAS No. : 1189953-78-3
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
1 mg | ¥3300 | In-stock | |
5 mg | ¥9600 | In-stock | |
10 mg | 询价 | ||
50 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
Erlotinib D6 hydrochloride (CP-358774 D6 hydrochloride) a deuterium labeled Erlotinib Hydrochloride. Erlotinib Hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM[1]. |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
分子量 |
435.93 |
|||||||||
Formula |
C22H18D6ClN3O4 |
|||||||||
CAS 号 |
1189953-78-3 |
|||||||||
中文名称 |
盐酸埃罗替尼 d6 (盐酸盐) |
|||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
|||||||||
储存方式 |
|
|||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
O-Desmethylangolensin 纯度: 98.65%
O-Desmethylangolensin 是大豆异黄酮经过肠道微生物代谢的代谢物,具有抗氧化活性。
O-Desmethylangolensin Chemical Structure
CAS No. : 21255-69-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥1000 | In-stock | |
10 mg | ¥1500 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
O-Desmethylangolensin is a metabolite of soy isoflavone, daidzein metabolized by gut microbiota. O-Desmethylangolensin possesses antioxidant activity[1][2]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
体外研究 (In Vitro) |
O-Desmethylangolensin (O-DMA) inhibits the growth of HepG2 cells at higher doses (~30% decrease at 75 μM)[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
258.27 |
||||||||||||||||
Formula |
C15H14O4 |
||||||||||||||||
CAS 号 |
21255-69-6 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 250 mg/mL (967.98 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Irinotecan hydrochloride (Synonyms: 伊立替康盐酸盐; (+)-Irinotecan hydrochloride; CPT-11 hydrochloride) 纯度: 99.24%
Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) 是一种拓扑异构酶 I (topoisomerase I) 抑制剂,可用于结肠癌和直肠癌的研究。
Irinotecan hydrochloride Chemical Structure
CAS No. : 100286-90-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥715 | In-stock | |
50 mg | ¥650 | In-stock | |
100 mg | ¥990 | In-stock | |
200 mg | ¥1550 | In-stock | |
500 mg | ¥3150 | In-stock | |
1 g | 询价 | ||
5 g | 询价 |
* Please select Quantity before adding items.
生物活性 |
Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer[1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
||||||||||||||||
体外研究 (In Vitro) |
Irinotecan hydrochloride is a topoisomerase I inhibitor. Irinotecan inhibits the growth of LoVo and HT-29 cells, with IC50s of 15.8 ± 5.1 and 5.17 ± 1.4 μM, respectively, and induces similar amounts of cleavable complexes in both in LoVo and HT-29 cells[2]. Irinotecan suppresses the proliferation of human umbilical vein endothelial cells (HUVEC), with an IC50 of 1.3 μM[3]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
Irinotecan (CPT-11, 5 mg/kg) significantly inhibits the growth of tumors by intratumoral injection daily for 5 days, on two consecutive weeks in rats, and such effects also occur via continuous intraperitoneal infusion by osmotic minipump into mice. However, Irinotecan (10 mg/kg) shows no effect on the growth of tumor by i.p[1]. Irinotecan (CPT-11, 100-300 mg/kg, i.p.) apparently suppresses tumor growth of HT-29 xenografts in athymic female mice by day 21. The two groups of Irinotecan (125 mg/kg) plus TSP-1 (10 mg/kg per day) or Irinotecan (150 mg/kg) in combination TSP-1 (20 mg/kg per day) are nearly equally effective and inhibit tumor growth 84% and 89%, respectively, and both are more effective than Irinotecan alone at doses of 250 and 300 mg/kg[3]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
623.14 |
||||||||||||||||
Formula |
C33H39ClN4O6 |
||||||||||||||||
CAS 号 |
100286-90-6 |
||||||||||||||||
中文名称 |
伊立替康盐酸盐 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 250 mg/mL (401.19 mM; Need ultrasonic) H2O : 3.33 mg/mL (5.34 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
Cell Assay [2] |
Exponentially growing cells are seeded in 20 cm2 dishes with an optimal cell number for each cell line (20,000 for LoVo cells, 100,000 for HT-29 cells). They are treated 2 days later with increasing concentrations of irinotecan or SN-38 for one cell doubling time (24 h for LoVo cells, 40 h for HT-29 cells). After washing with 0.15 M NaCl, the cells are further grown for two doubling times in normal medium, detached from the support with trypsin-EDTA and counted in a hemocytometer. The IC50 values are then estimated as the drug concentrations responsible for 50% growth inhibition as compared with cells incubated without drug[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
---|---|
Animal Administration [1] |
Irinotecan has been administered by intratumoral injection at 0.1 cc volume of the appropriate solution, for a doses of 5 mg/kg daily for 5 days, on two consecutive weeks, followed by a 7-days rest period, referred to as one cycle of therapy. Rats receive three cycles over a period of 8 weeks. Control animals receive 0.1 cc of sterile 0.9% sodium chloride solution by intratumoral injection in the same rule of administration as that of animals of group II[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
【简单介绍】
【详细说明】
宁波新芝聚能恒温超声波萃取仪Scientz-250C
产品说明
1、C系列聚能恒温超声萃取仪是应用现代超声波技术结合智能低温恒温系统作为物理手段的新型超声波萃取/提取装置
主要由大功率超声波发生系统、加热系统、压缩机制冷系统、测温控温系统、搅拌系统等组成。
2、采用20KHz聚焦式大功率超声波换能器,直接将超声波探头浸入盛放物料的容器中,温度传感器对物料进行测温
把盛有物料的容器放入恒温容器内,可以根据用户的需要设置所需温度,使物料在低温恒温的环境下在超声波的直接作用下充分快速的萃取/提取。
产品特征
1、采用触摸屏集成控制技术
2、超声波采用锁相环频率自动跟踪技术
3、友好美观的人机界面操作即可设置数据、存储数据和控制工作状态
4、换能器的振荡频率经相位取样使锁相环实现频率自动跟踪
5、功率设定和温度测量电路使单片机实现超声波发射功率和超温保护及报警功能
6、7寸TFY触摸屏显示
技术参数
型号 |
Scientz-250C |
超声功率MAX |
650 W |
反应瓶容积 |
250 ml |
探头直径 |
Ф6 mm |
功率可调范围 |
5%-100% |
超声频率 |
22KHz±1KHz |
超声总时间 |
1-999 min可设 |
超声时间 |
1-99 S可设 |
间隙时间 |
1-99 S可设 |
搅 拌 仪 |
1%-30%可设(最高转速1000 r/min)有需要的用户可选购与四口瓶配用 |
压缩机功率 |
500 W |
加热功率 |
2000 W |
控温方式 |
PID自动控温 |
测温方式 |
双通道测温,监控反应体系和恒温工作槽内实时温度。 |
控温范围 |
0-99 ℃ |
控温波动度 |
≦±1 ℃ |
恒温容积 |
6 L |
异常报警功能 |
有,设备具有故障自诊断及报警提示功能 |
运行记录方式 |
设备具有工作曲线画面,全程记录运行中温度等参数变化信息 |
设备控制方式 |
7寸TFT触摸屏显示与单片机集成控制 |
设备操作方式 |
触屏上直接操作,设置温度、功率、时间等参数 |
USB通讯口 |
设备自带USB通讯口,插上优盘,可将曲线等信息以图片形式保存到优盘 |
远程通讯串口 |
此功能为选配项,有需要的用户可选购(含上位机软件)与电脑相连 |
反 应 瓶 |
常规为三口瓶,有需要的用户可选购五口瓶 |
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Erlotinib-d6 (Synonyms: CP-358774-d6; NSC 718781-d6; OSI-774-d6)
Erlotinib D6 是 Erlotinib (CP-358774) 的氘代物。Erlotinib 是一种直接作用的 EGFR 酪氨酸激酶抑制剂,对人 EGFR 的 IC50 为 2 nM。
Erlotinib-d6 Chemical Structure
CAS No. : 1034651-23-4
规格 | 价格 | 是否有货 | |
---|---|---|---|
5 mg | ¥7000 | 询问价格 & 货期 |
* Please select Quantity before adding items.
Erlotinib-d6 的其他形式现货产品:
生物活性 |
Erlotinib D6 (CP-358774 D6) is a deuterium labeled Erlotinib (CP-358774). Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR[1]. |
---|---|
分子量 |
399.47 |
Formula |
C22H17D6N3O4 |
CAS 号 |
1034651-23-4 |
中文名称 |
埃罗替尼 d6 |
运输条件 |
Room temperature in continental US; may vary elsewhere. |
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务